Cite

HARVARD Citation

    Tan, D. et al. (n.d.). 69OLarotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach. Annals of oncology. p. . [Online]. 
  
Back to record